Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Bohne

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Wiley Interdisciplinary Reviews. RNA|January 16, 2016
The KSHV RNA regulator ORF57: target specificity and its role in the viral life cycleCarolin Vogt, Jens Bohne
Current Opinion in Molecular Therapeutics|June 7, 2008
Genotoxicity in gene therapy: an account of vector integration and designer nucleasesJens Bohne, Toni Cathomen
Virus Genes|August 2, 2017
The retroviral vector family: something for everyoneCarina Elsner, Jens Bohne
FEBS Letters|April 6, 2004
Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicingJens Bohne, Hans-Georg Kräusslich
Wiley Interdisciplinary Reviews. RNA|July 8, 2020
Two sides of the same medal: Noncoding mutations reveal new pathological mechanisms and insights into the regulation of gene expressionAmelie S Wachs, Jens Bohne
Journal of Virology|January 19, 2007
New way of regulating alternative splicing in retroviruses: the promoter makes a differenceJens Bohne, Axel Schambach, Daniela Zychlinski
RNA Biology|January 18, 2013
U1 snRNP-mediated poly(A) site suppression: beneficial and deleterious for mRNA fateJörg Langemeier, Maximilian Radtke, Jens Bohne
Nucleic Acids Research|February 11, 2005
Splicing of human immunodeficiency virus RNA is position-dependent suggesting sequential removal of introns from the 5' endJens Bohne, Harald Wodrich, Hans-Georg Kräusslich
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2006
Retrovirus vectors: toward the plentivirus?Christopher Baum, Axel Schambach, Jens Bohne, et al.
Nucleic Acids Research|October 16, 2018
Site specific target binding controls RNA cleavage efficiency by the Kaposi's sarcoma-associated herpesvirus endonuclease SOXAaron S Mendez, Carolin Vogt, Jens Bohne, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Wiley Interdisciplinary Reviews. RNA|January 16, 2016
The KSHV RNA regulator ORF57: target specificity and its role in the viral life cycleCarolin Vogt, Jens Bohne
Current Opinion in Molecular Therapeutics|June 7, 2008
Genotoxicity in gene therapy: an account of vector integration and designer nucleasesJens Bohne, Toni Cathomen
Virus Genes|August 2, 2017
The retroviral vector family: something for everyoneCarina Elsner, Jens Bohne
FEBS Letters|April 6, 2004
Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicingJens Bohne, Hans-Georg Kräusslich
Wiley Interdisciplinary Reviews. RNA|July 8, 2020
Two sides of the same medal: Noncoding mutations reveal new pathological mechanisms and insights into the regulation of gene expressionAmelie S Wachs, Jens Bohne
Journal of Virology|January 19, 2007
New way of regulating alternative splicing in retroviruses: the promoter makes a differenceJens Bohne, Axel Schambach, Daniela Zychlinski
RNA Biology|January 18, 2013
U1 snRNP-mediated poly(A) site suppression: beneficial and deleterious for mRNA fateJörg Langemeier, Maximilian Radtke, Jens Bohne
Nucleic Acids Research|February 11, 2005
Splicing of human immunodeficiency virus RNA is position-dependent suggesting sequential removal of introns from the 5' endJens Bohne, Harald Wodrich, Hans-Georg Kräusslich
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2006
Retrovirus vectors: toward the plentivirus?Christopher Baum, Axel Schambach, Jens Bohne, et al.
Nucleic Acids Research|October 16, 2018
Site specific target binding controls RNA cleavage efficiency by the Kaposi's sarcoma-associated herpesvirus endonuclease SOXAaron S Mendez, Carolin Vogt, Jens Bohne, et al.
Pageof 4